Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders-A Pilot Study

NCT03832413 is registered in ClinicalTrials.gov with QuantalX Neuroscience as lead sponsor.

NCT NCT03832413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03832413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders-A Pilot Study
Lead sponsor
QuantalX Neuroscience
Phase
Observational
Overall status
Completed
Start date
April 23, 2018
Completion date
February 14, 2022
Enrollment
193 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abd, adhd, cognitive decline, cognitive impairment, dementia, fibromyalgia, healthy, mci, pdd, ptsd, stroke, tbi